MMindy finds federal opportunities that fit you, daily.Try free →
Home/Contractors/Amgen INC.

Federal Contractor Profile

Amgen INC.

Federal contracting record: $722M obligated across 16 awards from 3 agencies, FY 2016–2026.

$722M
Total Obligated
16
Award Records
3
Agencies Served
3
NAICS Codes
OverviewContractsAgenciesNAICS

Company Profile

Parent UEI (Unique Entity Identifier)

D92HARF1LKA9

CAGE Code

0JVZ6

Registered Entities (UEIs)

3 under this organization

Address

1 AMGEN CENTER DR, THOUSAND OAKS, CA, 913201799

First Federal Award

Oct 13, 2015

Most Recent Award

Sep 4, 2025

Federal Sales Analytics

Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.

Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).

Top Federal Agencies

  • Department of Health and Human Services

    100.0% of total obligations

    $1.0B

  • Department of Veterans Affairs

    0.0% of total obligations

    $140K

  • Department of Justice

    0.0% of total obligations

    $13K

Top NAICS Activity

  • 541714

    RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)

    3 awards

    $801M

  • 325414

    BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING

    5 awards

    $193M

  • 325412

    PHARMACEUTICAL PREPARATION MANUFACTURING

    11 awards

    $7.4M

Recent Federal Awards

DateAgencyNAICSDescriptionAmount
Mar 6, 2026Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN.$60M
Sep 4, 2025Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF ROMIPLOSTIM FOR TREATMENT OF HEMATOPOIETIC SUBSYNDROME-ACUTE RADIATION SYNDROME (HS-ARS) AND CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT) AND A DRUG DELIVERY DEVICE FEASIBILITY PROJECT WITH AN OPTION TO$2.3M
Jul 15, 2025Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN.$90M
Sep 18, 2024Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN.$129M
Aug 8, 2024Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714VENDOR MANAGED INVENTORY (VMI) SERVICES FOR USG PROCURED 165,906 DOSES OF NEULASTA PRODUCT TO MITIGATE INJURIES CAUSED BY EXPOSURE TO CHEMICAL, BIOLOGICAL THREAT AGENTS, PHYSICAL, RADIOLOGIC AND NUCLEAR EXPOSURES.$274K
Mar 12, 2024Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714VENDOR MANAGED INVENTORY (VMI) SERVICES FOR USG PROCURED 165,906 DOSES OF NEULASTA PRODUCT TO MITIGATE INJURIES CAUSED BY EXPOSURE TO CHEMICAL, BIOLOGICAL THREAT AGENTS, PHYSICAL, RADIOLOGIC AND NUCLEAR EXPOSURES.$580K
Oct 1, 2023Department of Veterans Affairs260-NETWORK CONTRACT OFFICE 20 (36C260)325412TAVNEOS (AVACOPAN)$129K
Sep 20, 2023Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN.$205M
Sep 7, 2023Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325414RTOR NUMBER: RTOR-CSF-0004 MAINTENANCE OF PREVIOUSLY PURCHASED COLONY STIMULATING FACTOR(S) (G- OR GM-CSF) FOR MITIGATION OF NEUTROPENIA ARISING FROM EXPOSURE TO IONIZING RADIATION$66K
Sep 7, 2023Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325414IGF::OT::IGF RTOR NUMBER: RTOR-CSF-0005 ACQUISITION OF COLONY STIMULATING FACTOR(S) (G-CSF OR GM-CSF) FOR MITIGATION OF NEUTROPENIA ARISING FROM EXPOSURE TO IONIZING RADIATION$50K
Aug 22, 2023Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325412NPLATE ADMINISTRATION KIT DEVELOPMENT FOR THE TREATMENT OF APPROVED INDICATIONS, INCLUDING ACUTE RADIATION SYNDROME (ARS)$7.3M
Sep 28, 2022Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN.$290M
Jul 20, 2022Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF ROMIPLOSTIM FOR TREATMENT OF HEMATOPOIETIC SUBSYNDROME-ACUTE RADIATION SYNDROME (HS-ARS) AND CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT) AND A DRUG DELIVERY DEVICE FEASIBILITY PROJECT WITH AN OPTION TO$475K
Jan 31, 2022Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF ROMIPLOSTIM FOR TREATMENT OF HEMATOPOIETIC SUBSYNDROME-ACUTE RADIATION SYNDROME (HS-ARS) AND CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT) AND A DRUG DELIVERY DEVICE FEASIBILITY PROJECT WITH AN OPTION TO$2.2M
Sep 13, 2021Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325414RTOR NUMBER: RTOR-CSF-0004 MAINTENANCE OF PREVIOUSLY PURCHASED COLONY STIMULATING FACTOR(S) (G- OR GM-CSF) FOR MITIGATION OF NEUTROPENIA ARISING FROM EXPOSURE TO IONIZING RADIATION$49K
Apr 1, 2021Department of Veterans Affairs245-NETWORK CONTRACT OFFICE 5 (36C245)325412AFLURIA QUADRIVALENT 0.5ML SINGLE-DOSE, PRE-FILLED QUADRIVALENT SYRINGES DESIGNATED FOR PERSONS 36 MONTHS AND OLDER PKG OF 10, NDC: 33332-0321-01$75K
Mar 31, 2021Department of JusticeFCI TERMINAL ISLAND325412TO PROVIDE FLU SHOTS FOR FY 2021 FOR STAFF AT THE FEDERAL CORRECTIONAL INSTITUTION TERMINAL ISLAND, CA.$8K
Mar 31, 2021Department of JusticeFCI TERMINAL ISLAND325412TO PROVIDE FLU SHOTS FOR FY 2021 FOR STAFF AT THE FEDERAL CORRECTIONAL INSTITUTION TERMINAL ISLAND, CA.$3K
Mar 31, 2021Department of JusticeFCI TERMINAL ISLAND325412TO PROVIDE FLU SHOTS FOR FY 2021 FOR STAFF AT THE FEDERAL CORRECTIONAL INSTITUTION TERMINAL ISLAND, CA.$3K
Sep 26, 2019Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF ROMIPLOSTIM FOR TREATMENT OF HEMATOPOIETIC SUBSYNDROME-ACUTE RADIATION SYNDROME (HS-ARS) AND CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT) AND A DRUG DELIVERY DEVICE FEASIBILITY PROJECT WITH AN OPTION TO$21M
Sep 13, 2018Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325414IGF::OT::IGF RTOR NUMBER: RTOR-CSF-0005 ACQUISITION OF COLONY STIMULATING FACTOR(S) (G-CSF OR GM-CSF) FOR MITIGATION OF NEUTROPENIA ARISING FROM EXPOSURE TO IONIZING RADIATION$154M
Aug 20, 2018Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325414RTOR NUMBER: RTOR-CSF-0004 MAINTENANCE OF PREVIOUSLY PURCHASED COLONY STIMULATING FACTOR(S) (G- OR GM-CSF) FOR MITIGATION OF NEUTROPENIA ARISING FROM EXPOSURE TO IONIZING RADIATION$542K
Sep 30, 2016Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325414IGF::OT::IGF FOR OTHER FUNCTIONS PROJECT: ACQUISITION OF COLONY STIMULATING FACTOR(S) (G-CSF OR GM-CSF) FOR MITIGATION OF NEUTROPENIA ARISING FROM EXPOSURE TO IONIZING RADIATION (RTOR-CSF-0003)$38M

Related Contractors

Other companies active in NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY).

Analytic Services INC.

$2.8B

The Boeing Company

$525M

Advanced Technology International

$509M

Technical Resources International, INC.

$390M

Icon Public Limited Company

$358M

Allucent Government Services (US) LLC

$350M

Siga Technologies, INC.

$304M

Thermo Fisher Scientific INC.

$149M

Track Amgen INC. Recompetes Before They Post

Mindy monitors Amgen INC.'s active contracts and alerts you 12 months before they expire — so you can position to compete on recompete.

Get Free Recompete Alerts